Newsletter Subject

Investing in Einstein's Last Secret

From

empirefinancialresearch.com

Email Address

wtilson@exct.empirefinancialresearch.com

Sent On

Thu, Aug 26, 2021 08:33 PM

Email Preheader Text

Editor's note: Over the next two days, we're doing something different here at Empire Financial Dail

Editor's note: Over the next two days, we're doing something different here at Empire Financial Daily... Our colleague Dave Lashmet has given us permission to "unlock" a classic issue of his high-end Stansberry Venture Technology publication. Dave is a biotech expert at our sister company Stansberry Research... In Venture Technology, he looks for tech breakthroughs […] Not rendering correctly? View this e-mail as a web page [here](. [Empire Financial Daily] Editor's note: Over the next two days, we're doing something different here at Empire Financial Daily... Our colleague Dave Lashmet has given us permission to "unlock" a classic issue of his high-end Stansberry Venture Technology publication. Dave is a biotech expert at our sister company Stansberry Research... In Venture Technology, he looks for tech breakthroughs and medical innovations that have massive, triple-digit upside for investors. It's a strategy that has led readers who followed his advice to double their money 25 times over the past six years. Today and tomorrow, we'll share an adapted version of this story from 2017, in which Dave details an incredible medical advancement... --------------------------------------------------------------- Investing in Einstein's Last Secret By Dave Lashmet In October 1957, America got Sputnik-ed... The Soviet Union had beaten us to space and put a satellite in orbit. Moscow radio announced the news... and within hours, ham-radio operators and amateur astronomers across the nation were listening in. "Beeeep, beeeep, beeeep" emerged from fireside radios across America. This was the second stage of the nuclear arms race that physicist Albert Einstein warned about... You may know that Einstein kicked off the Manhattan Project in the Arizona desert. It started with his 1939 letter to President Franklin D. Roosevelt about "extremely powerful bombs." Einstein also warned of a nuclear arms race – at the time against Nazi Germany.                                                                                                           When World War II ended, the Soviet Union replaced the Nazis in the weapons race... and in the space race that followed. And a few months after the Sputnik launch, a new, practical application of Einstein's second theory happened to land at the U.S. Patent Office. The file was labeled "Top Secret." Very few patent examiners can touch classified files. Among physics experts, there's only one guy... And he gets one secure cabinet. So, for a decade, the file remained locked up and hidden. Two words justified all the secrecy: 'death rays'... It was thought that lasers were key to a death-ray weapon... and the Pentagon was very interested in building one. Obviously, we didn't end up with death rays. But lasers did lead to something else – and it became a powerful investment opportunity... Lasers first appeared as a mere footnote in Albert Einstein's paper on black-body radiation... published 100 years ago. To wit, Einstein said that it might be possible to create light particles – "photons" – by applying electricity to a material. And all this was highly theoretical: light itself was considered a wave. By the 1950s, though, physicists proved out part of this theory with "masers": Microwave Amplification by the Stimulated Emission of Radiation. (A laser is comprised of photons stimulated in the same way.) A guy named Gordon Gould figured all this out in November 1957 – a month after Sputnik. His Top Secret patent application was soon received by the U.S. government. Meanwhile, physicist Theodore Maiman published proof-of-concept experiments using rose quartz crystals. Then, a second team used a gas matrix. And finally, it was proven in solid-state electronics. From there, lasers disseminated broadly... from cutting lasers to fiber optics and ultimately CD players. An industry with hundreds of businesses and billions of dollars in revenue developed around these electronics... But no death rays followed. So the government unlocked the filing cabinet. It pulled out Gordon Gould's patent application. And it issued him a U.S. patent for the laser – which everyone was violating. Fair to say, the industry fought back. Gould trudged through a 30-year patent battle. But the Federal Appeals Court finally ruled in his favor in the 1980s. And his 40 patents on lasers lasted until 2005... Gould retired a rich man, despite signing away some 80% of his laser patent rights to pay for the patent battle. And though he didn't win immediate acclaim for inventing the laser – thanks to the secrecy around death rays – Gordon Gould is today enshrined in the National Inventors Hall of Fame. The big developments happened with medical lasers. And the medical-device segment of the laser market soon became a rich ground for investors... Medical-device firms are a great balance for the drug developers in my Stansberry Venture Technology portfolio. One key attribute of these companies is that they don't fall to zero... Unlike a one-drug, developmental-stage company – which can fail at any time – firms with approved devices stabilize your portfolio while still allowing it to grow. For decades, the U.S. Food and Drug Administration ("FDA") has reviewed new medical devices. That means there's government approval for U.S. sales, as well as FDA-approved marketing materials. Plus, part of the approval process is reviewing patents. So once a device appears on the list, it means that it's time for the firm to make money... not spend it. --------------------------------------------------------------- Recommended Links: [The Big Electric Vehicle Story Everyone's Missing]( While investors are obsessed with Tesla's surge, legendary investor Whitney Tilson says an even bigger EV story will provide the highest gains. [Click here to learn more](. --------------------------------------------------------------- [Here's what you missed this week]( There's a growing political and economic crisis that no one seems to understand. And it's already impacting you in ways you've probably overlooked. The last time this top analyst found an opportunity like this, readers saw 777% gains. But today's opportunity could be much bigger. [Get all the details right here](. --------------------------------------------------------------- To find breakthroughs, we must be selective... We've found a promising new device from an established firm. It's profitable, cash-rich, growing, and trading at a fair price. Plus, the breakthrough medical procedure tied to this laser is already approved by the FDA. Earlier, I mentioned "Einstein's last secret"... The secret is that light is a particle. Richard Feynman made Einstein's theory of light particles (photons) stronger using quantum electro-dynamics, or QED. But again, that was just a theory. In practice, this point wasn't proven until an experiment in July 2010... where Dutch and German scientists proved that photons are physical particles. Here's a picture from that experiment of light particles frozen in place, inside a mirrored chamber... Now, if light is made of particles, this means you can use photons to deliver energy to a target tissue. For surface targets, proton beams already have perfect accuracy. But protons are far heavier than photons. Think of a photon like a BB pellet... and a proton as a wrecking ball. One can crack a window – the other can bring down the house. That's why proton beams were first used in medicine to treat eye tumors. You can set how far you want them to travel and where they should stop. That spares the optic nerve and brain behind your eyes... So you cure the tumor, but don't go blind. Eye tumors are rare. But sometimes, other late-stage cancer spreads there. And having a safe and effective treatment for eye tumors that spares vision helps thousands of people in the U.S. each year. The FDA approved this same precision power for a new laser system... Instead of super-heavy protons, this new laser system uses much lighter photons – so it can handle more delicate surgeries. This system allows a new type of corrective vision surgery for your eye... and it has big advantages to current surgical competitors... Unlike in LASIK surgery, doctors don't have to cut a flap of your eye. And unlike in PRK surgery, they don't have to grind down the front of your eye. Instead, your eye stays mostly intact and protected from the outside environment... Surgeons can wear away material inside your eye to correct your vision. Plus, this new procedure hurts a lot less because it spares your nerves. That's putting Einstein's last secret into use: throwing light exactly the right distance to get a clinical effect, without damaging either the surface or the back of your eye... and sparing your nerves and brain. I'll continue with the details tomorrow. Until then... Regards, Dave Lashmet August 26, 2021 Editor's note: As we mentioned earlier, over the past six years, Stansberry Venture Technology subscribers who followed Dave's advice could have doubled their money 25 times. And right now, Dave is seeing a big new development unfolding that could have a huge effect on your money – and your way of life – in the months ahead. In a brand-new presentation, he shares all the details... including how you can profit. [Watch it right here](. If someone forwarded you this e-mail and you would like to be added to my e-mail list to receive e-mails like this every weekday, simply [sign up here](. © 2021 Empire Financial Research. All rights reserved. Any reproduction, copying, or redistribution, in whole or in part, is prohibited without written permission from Empire Financial Research, 601 Lexington Ave., 20th Floor, New York, NY 10022 [www.empirefinancialresearch.com.]( You received this e-mail because you are subscribed to Empire Financial Daily. [Unsubscribe from all future e-mails](

Marketing emails from empirefinancialresearch.com

View More
Sent On

07/11/2023

Sent On

06/11/2023

Sent On

04/11/2023

Sent On

03/11/2023

Sent On

02/11/2023

Sent On

01/11/2023

Email Content Statistics

Subscribe Now

Subject Line Length

Data shows that subject lines with 6 to 10 words generated 21 percent higher open rate.

Subscribe Now

Average in this category

Subscribe Now

Number of Words

The more words in the content, the more time the user will need to spend reading. Get straight to the point with catchy short phrases and interesting photos and graphics.

Subscribe Now

Average in this category

Subscribe Now

Number of Images

More images or large images might cause the email to load slower. Aim for a balance of words and images.

Subscribe Now

Average in this category

Subscribe Now

Time to Read

Longer reading time requires more attention and patience from users. Aim for short phrases and catchy keywords.

Subscribe Now

Average in this category

Subscribe Now

Predicted open rate

Subscribe Now

Spam Score

Spam score is determined by a large number of checks performed on the content of the email. For the best delivery results, it is advised to lower your spam score as much as possible.

Subscribe Now

Flesch reading score

Flesch reading score measures how complex a text is. The lower the score, the more difficult the text is to read. The Flesch readability score uses the average length of your sentences (measured by the number of words) and the average number of syllables per word in an equation to calculate the reading ease. Text with a very high Flesch reading ease score (about 100) is straightforward and easy to read, with short sentences and no words of more than two syllables. Usually, a reading ease score of 60-70 is considered acceptable/normal for web copy.

Subscribe Now

Technologies

What powers this email? Every email we receive is parsed to determine the sending ESP and any additional email technologies used.

Subscribe Now

Email Size (not include images)

Font Used

No. Font Name
Subscribe Now

Copyright © 2019–2025 SimilarMail.